Oxford Nanopore trims medium-term guidance, shares slide
2nd Mar 2026 09:43
(Sharecast News) - Shares in Oxford Nanopore Technologies fell sharply in morning trading on Monday, after the FTSE 250 firm lowered its medium-term guidance.
Read moreBerenberg lowers target price on Oxford Nanopore
2nd Mar 2026 09:40
(Sharecast News) - Analysts at Berenberg lowered their target price on Oxford Nanopore Technologies from 250p to 230p on Monday after the nanopore sequencing products developer released its full-year 2025 results.
Read moreBroker tips: Centrica, Vanquis Banking, Oxford Nanopore
2nd Mar 2026 07:07
(Sharecast News) - Jefferies downgraded Centrica on Monday to 'hold' from 'buy' as it pointed to a more balanced risk-reward on the stock at current trading.
Read moreRevenues beat guidance at Oxford Nanopore, shares spark
12th Jan 2026 08:40
(Sharecast News) - Shares in Oxford Nanopore Technologies surged in early trading on Monday, after the FTSE 250 firm said full-year sales had beaten guidance.
Read moreOxford Nanopore appoints Francis Van Parys as CEO
8th Dec 2025 07:35
(Sharecast News) - Oxford Nanopore Technologies has appointed Francis Van Parys as chief executive, succeeding Gordon Sanghera, who has led the company since its inception in 2005.
Read moreOxford Nanopore shares jump on guidance upgrade
7th Nov 2025 11:20
(Sharecast News) - Shares in Oxford Nanopore Technologies jumped on Friday after the company revealed that annual revenue growth would be at the top end of forecasts.
Read moreLondon close: Stocks lower amid surge in gilt yields
2nd Sep 2025 17:31
(Sharecast News) - London stocks closed lower on Tuesday as rising borrowing costs and a sharp fall in sterling weighed on sentiment.
Read moreOxford Nanopore reports stronger-than-expected first half, shares slide
2nd Sep 2025 10:03
(Sharecast News) - Oxford Nanopore Technologies shares were in the red on Tuesday morning, even after it reported a stronger-than-expected first half, with revenue growth across all regions and customer segments and a narrowed loss as it reaffirmed its full-year guidance.
Read moreLondon close: Stocks mixed ahead of crucial jobs data
11th Aug 2025 17:26
(Sharecast News) - London stocks ended Monday mixed as optimism over a potential resolution to the Ukraine conflict was tempered by caution ahead of key economic data later this week.
Read moreGordon Sanghera to step down as Oxford Nanopore CEO
11th Aug 2025 07:19
(Sharecast News) - Oxford Nanopore Technologies announced Monday that Gordon Sanghera, its co-founder and chief executive officer, would step down from his role and the board by the end of 2026.
Read moreOxford Nanopore suing MGI Australia over alleged patent infringements
6th Aug 2025 11:45
(Sharecast News) - Oxford Nanopore Technologies announced the launch of legal proceedings against MGI Australia on Wednesday, alleging infringement of four Australian patents, following the release of MGI's 'Cyclone SEQ WT-02' sequencing device in Australia.
Read moreImpressive H1 from Oxford Nanopore should allay investor concerns, says Berenberg
21st Jul 2025 09:17
(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Monday after the molecular tech group updated the market on a strong first-half performance, something which broker Berenberg says has "de-risked" the delivery of full-year guidance.
Read moreOxford Nanopore delivers 'strong' H1 performance, reported revenues up 25pc YOY
21st Jul 2025 07:04
(Sharecast News) - Molecular technology business Oxford Nanopore said on Monday that it had delivered a "strong" first half performance, with reported revenues expected to be up by a quarter year-on-year.
Read moreLondon close: Stocks fall, pound weakens further on rising bond yields
13th Jan 2025 15:19
(Sharecast News) - London stocks ended Monday in negative territory, pressured by rising bond yields and diminished expectations for near-term interest rate cuts.
Read moreOxford Nanopore shares jump on margin guidance
13th Jan 2025 07:54
(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Monday after the DNA and RNA analysis firm reported an acceleration in momentum towards the end of the year, pointing to higher-than-expected margins.
Read more